The EU exported €366.2 billion worth of medicinal and pharmaceutical products in 2025, importing €145.7 billion, according to Eurostat, resulting in a record trade surplus of €220.5 billion.
The figures from the EU’s statistics agency show that6 compared with 2024, exports rose by 16.0% (from €315.7 billion), and imports increased by 21.0% (from €120.4 billion).
Ireland was the EU’s largest exporter of medicinal and pharmaceutical products to countries outside the EU in 2025, with exports valued at €93.8 billion, followed by Germany (€67.9 billion) and Belgium (€38.5 billion).
The largest importers from countries outside the EU were Italy (€27.5 billion), Belgium (€24.7 billion) and Germany (€24.2 billion).
The main destination for extra-EU exports of medicinal and pharmaceutical products in 2025 was the United States, accounting for 43.8% of all exports, valued at €160.6 billion. Switzerland was the second largest partner (16.3%, €59.7 billion), followed by the United Kingdom (5.6%, €20.6 billion).
Most of the imports to the EU came from the United States (41.2%, €60.1 billion), Switzerland (28.4%, €41.4 billion) and China (9.0%, €13.1 billion).
